Camrelizumab Combined With Apatinib in the Treatment of Advanced Sarcomatoid Carcinoma or Carcinosarcoma
Status:
Recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
This study is to explore the treatment of advanced sarcomatoid carcinoma or Carcinosarcoma
with Carrelizumab combined with Apatinib, in order to provide guidance and experience for new
combined therapy in clinic.